| NP | nasopharynx, nasopharyngeal; near point; necrotizing pancreatitis; neonatal-perinatal; neuritic plag... |
|---|---|
| NUG | necrotizing ulcerative gingivitis |
| PNE | peripheral neuroepithelioma; plasma norepinephrine; pneumoencephalography; pseudomembranous necrotiz... |
| SBE | Subacute Bacterial Endocarditis; 아급성 세균성 심내막염 |
| SCD | 1) Sickle Cell Disease 2) Subacute Combined Degeneration |
| palindromic encephalopathy | A relatively mild form which tends to recur. (05 Mar 2000) |
|---|---|
| pancreatic encephalopathy | A metabolic encephalopathy associated with extensive pancreatic necrosis. (05 Mar 2000) |
| recurrent encephalopathy | A progressive form of encephalopathy occurring in young members of the same family; characterised by headache, vertigo, truncal ataxia, drowsiness and stupor, speech impairments, choreic-athetoid movements, and sometimes convulsions. (05 Mar 2000) |
| metabolic encephalopathy | Encephalopathy characterised by memory loss, vertigo, and generalised weakness, due to metabolic brain disease including hypoxia, ischemia, hypoglycaemia, or secondary to other organ failure such as liver or kidney. (05 Mar 2000) |
| Wernicke-Korsakoff encephalopathy | See: Wernicke's syndrome, Korsakoff's syndrome. (05 Mar 2000) |
| Wernicke's encephalopathy | <neurology> Encephalopathy associated with thiamin deficiency. Usually associated with chronic alcohol abuse. Other features include loss of memory and confabulation. Origin: Gr. Pathos = disease (27 Sep 1997) |
| portal-systemic encephalopathy | An encephalopathy associated with cirrhosis of the liver, attributed to the passage of toxic nitrogenous substances from the portal to the systemic circulation; cerebral manifestations may include coma. Synonym: hepatic encephalopathy. (05 Mar 2000) |
| progressive subcortical encephalopathy | <radiology> Demyelinating disease due to papovavirus, seen in immunosuppressed hosts: lymphoma, leukaemia, AIDS, TB, sarcoidosis, organ transplant, most prominent in pareito-occipital white matter, NO contrast enhancement (12 Dec 1998) |
| hepatic encephalopathy | <neurology, pathology> A condition which is used to describe the deleterious effects of liver failure on the central nervous system. Features include confusion ranging to unresponsiveness (coma). A common cause is alcoholic cirrhosis. Treatment includes the binding and elimination of ammonia in the intestinal tract. General life support including respiratory support and cardiovascular support may also be required. See: encephalopathy for additional details. (27 Sep 1997) |
| saturnine encephalopathy | A metabolic encephalopathy, caused by the ingestion of lead compounds and seen particularly in early childhood; it is characterised pathologically by extensive cerebral oedema, status spongiosus, neurocytolysis, and some reactive inflammation; clinical manifestations include convulsions, delirium, and hallucinations. See: lead poisoning. Synonym: lead encephalitis, saturnine encephalopathy. (05 Mar 2000) |
| HIV encephalopathy | <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting. Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection. (09 Oct 1997) |
| pulmonary encephalopathy | Coma seen with advanced lung failure and resultant hypoventilation. Synonym: CO2 narcosis, hypoxic-hypercarbic encephalopathy, pulmonary encephalopathy. (05 Mar 2000) |
| severe postanoxic encephalopathy | Coma that develops a few days to 3 weeks after an acute hypoxic insult; the latter was usually severe enough to cause an initial bout of coma, which cleared, and was followed by a transient interval of apparent normality. Synonym: severe postanoxic encephalopathy. (05 Mar 2000) |
| hypernatraemic encephalopathy | Subarachnoid and subdural effusions in infants with hypernatraemic dehydration. (05 Mar 2000) |
| hypertensive encephalopathy | A metabolic encephalopathy caused by diffuse cerebral oedema; follows an abrupt elevation of blood pressure in a long-term hypertensive patient. (05 Mar 2000) |